Latest Health And Wellness Products News

Nuchev Limited (ASX: NUC) has secured a final Shanghai arbitration award requiring Nouvlait to pay about RMB9.1 million, including repayment of a disputed advance, losses and interest. The award is legally effective, but Nuchev expects court enforcement may be needed and has not yet received any money.

The Calmer Co. has pushed back the closing date of its $3.5 million renounceable entitlement offer to give shareholders more time to participate, including those overseas.

McPherson’s Limited has confirmed a $3.3 million total tax benefit following amended assessments by the ATO, linked to deductible costs from a strategic alliance announced in 2022.

Jatcorp Limited reported a striking 165% revenue increase in Q2 FY26, driven by strong demand in Australia, Hong Kong, and China. The company also secured $4.2 million through an entitlement offer to support its growth ambitions across Southeast Asia.

Jatcorp Limited has announced a fully underwritten pro-rata rights issue to raise approximately $4.2 million, aiming to strengthen working capital and accelerate growth in China and Southeast Asia. Eligible shareholders can subscribe at $0.15 per share with an option for additional shares under a Top-Up Facility.

McPherson’s Limited has secured a new $16.2 million debt facility with HSBC, significantly downsizing from its previous $52.5 million arrangement as part of its ongoing business transformation.

Holista Colltech has raised $2.295 million through a share placement to two international investors, aiming to bolster its operations and balance sheet. The move highlights the company’s ongoing efforts to support growth across its health and wellness divisions.

McPherson's Limited reported a 3.9% revenue decline in FY25 driven by exiting lower-margin brands, while core brands grew 1.9%. The company posted a statutory net loss of $15 million, weighed down by significant impairments as it completes a major operating model transformation.

Jatcorp Limited reported a robust 76% revenue increase in Q4 FY25, driven by strong Moroka® sales and expanded manufacturing capabilities, setting ambitious growth targets for FY26.

RLG Ltd has successfully raised $900,000 through a two-tranche placement to fund the development of its food and health products and expand global sales channels. The second tranche, involving options issuance, awaits shareholder approval.